Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines (Q36628049)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2006
edit
Language Label Description Also known as
English
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines
scientific article published on October 2006

    Statements

    Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines (English)
    Shirin Khambata-Ford
    Robert J Mayer
    Philip Gold
    Philip Stella
    Barry Mirtsching
    Allen L Cohn
    Andrew W Pippas
    Nozar Azarnia
    Zenta Tsuchihashi
    David J Mauro
    Eric K Rowinsky
    1 October 2006
    4914-4921

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit